Claims for Patent: 5,747,538

Summary for Patent: 5,747,538

Title:	Use of ginsenoside R.sub.0 or a plant extract containing same to promote collagen synthesis
Abstract:	The use of ginsenoside R.sub.0 or a plant extract containing same to prepare a cosmetic or pharmaceutical composition, particularly a skin care composition, for promoting collagen synthesis, particularly collagen I and/or collagen III synthesis. Said cosmetic or pharmaceutical composition is administered to a mammal, particularly a human being, in order to promote collagen synthesis. A method for promoting collagen synthesis in fibroblast growth media is also disclosed.
Inventor(s):	Meybeck; Alain (Courbevoie, FR), Bonte; Frederic (Courbevoie, FR), Dumas; Marc (Colombes, FR), Chaudagne; Catherine (Chatou, FR)
Assignee:	L.V.M.H. Recherche (Nanterre, FR)
Application Number:	08/716,363
Patent Claims:	1. A method of treatment of a mammal comprising administering to said mammal an amount effective to stimulate the synthesis of collagen, of ginsenoside of formula: ##STR2## wherein: the substituent R.sub.1 in the 3-position consists of the sugar residues beta-D-glucuronopyranoside and beta-D-glucopyranosyl linked together, represented by GlcA.sup.2 Glc, and the substituent R.sub.2 in the 28-position is a beta-D-glucopyranosyl residue, represented by Glc; or a plant extract containing it. 2. The method of claim 1, wherein said amount is effective to stimulate the synthesis of collagen selected from the group consisting of collagen I, collagen III and a combination of both. 3. The method of claim 1, wherein said treatment is for treating the effects of skin aging. 4. The method of claim 1, wherein said treatment is for promoting the synthesis of the skin tissue system. 5. The method of claim 1, wherein the treatment is for firming the skin. 6. The method of claim 1, wherein said treatment is for promoting healing or treating collagen deficiencies of the skin. 7. The method of claim 1, wherein the treatment is for healing wounds. 8. The method of claim 1, wherein said ginsenoside is present in a composition in an amount of between 0.001 and 5% by weight based on the total weight of the composition. 9. The method of claim 8, wherein aid composition contains an active substance selected form the group consisting of: Centella asiatica extract, asiatic acid, madecassic acid, asiaticoside, a horse chestnut extract, a knee holly extract, madecassoside, ivy saponins, sericoside, alpha-hydroxy acids, alpha-ketoglutarate, ascorbic acid, proline, L-hydroxyproline, lysine, hydroxylysine, glycine, forskolin, a forskolin derivative and a plant extract containing forskolin. 10. The method of claim 1, wherein said ginsenoside is in combination with a collagenase inhibitor. 11. The method of claim 10, wherein said collagenase inhibitor is retinoic acid. 12. A method of performing fibroblast culture comprising introducing into a fibroblast culture medium an amount effective to stimulate the synthesis of collagen by fibroblast cells present in said culture medium, of ginsenoside of formula: ##STR3## wherein: the substituent R.sub.1 in the 3-position consists of the sugar residues beta-D-glucuronopyranoside and beta-D-glucopyranosyl linked together, represented by GlcA.sup.2 Glc, and the substituent R.sub.2 in the 28-position is a beta-D-glucopyranosyl residue, represented by Glc; or a plant extract containing it. 13. The method of claim 12, wherein said ginsenoside is introduced at a concentration of 0.001 to 0.1% by weight into said culture medium. 14. The method of claim 13, wherein said fibroblast culture medium is an E199 culture medium to which has been introduced L-glutamine at a concentration of 2 mmol/l.

Details for Patent 5,747,538

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2014-03-18